Master Subscription Agreement + First Subscription Order for Access to Data on Drug Life-Cycle Insig

The Oregon Health Authority (OHA) is pursuing a sole-source procurement for a Master Subscription Agreement with IPD Analytics to access specialized drug life-cycle insights data. The contract will provide OHA's clinical pharmacists and leadership with comprehensive analytics covering drug pipelines, pricing, research, and regulatory information. Specifically, the subscription enables urgent reviews of critical healthcare topics, including COVID-19 countermeasure assessments. The procurement is being conducted without competitive bidding due to IPD Analytics being determined as the sole provider of these unique services. The contract opportunity was posted on February 8, 2022, with a proposal submission deadline of February 15, 2022. The services include access to a team of pharmacy experts who provide in-depth analysis and consulting services not available from other market providers. Evaluation appears to be based on the vendor's unique market position and specialized expertise in pharmaceutical data analysis.

The procurement is not explicitly restricted to disadvantaged enterprises or specific business types. IPD Analytics, a Florida-based company, is the incumbent and sole-source vendor for these services. The contract has a total estimated value of $25,000 for the initial subscription, with OHA reserving the right to renew the agreement up to $150,000 or for a maximum of five years. Existing subscribers to IPD Analytics' services include Washington State and Moda Health, indicating the vendor's established reputation in the healthcare data analysis market. The sole-source determination was based on comprehensive market research demonstrating that no alternative providers can meet OHA's specific data and consulting requirements. The procurement represents a targeted investment in specialized pharmaceutical intelligence to support critical healthcare decision-making and emergency response capabilities.